| IKT |
Inhibikase Therapeutics, Inc. |
21 Jan 2025 |
18 |
$0 |
4 |
President and CEO, Director |
22 Jan 2025, 16:05 |
| IKT |
Inhibikase Therapeutics, Inc. |
03 Jan 2025 |
3 |
$0 |
4 |
President and CEO, Director |
07 Jan 2025, 18:47 |
| IKT |
Inhibikase Therapeutics, Inc. |
01 Apr 2024 |
1 |
$0 |
4 |
President and CEO, Director, 10%+ Owner |
03 Apr 2024, 16:47 |
| IKT |
Inhibikase Therapeutics, Inc. |
01 Mar 2023 |
1 |
$0 |
4 |
President and CEO, Director, 10%+ Owner |
03 Mar 2023, 16:00 |
| IKT |
Inhibikase Therapeutics, Inc. |
16 Aug 2022 |
1 |
+$4,000 |
4 |
President and CEO, Director, 10%+ Owner |
16 Aug 2022, 16:25 |
| IKT |
Inhibikase Therapeutics, Inc. |
27 May 2022 |
1 |
+$4,880 |
4 |
President and CEO, Director, 10%+ Owner |
31 May 2022, 10:16 |
| IKT |
Inhibikase Therapeutics, Inc. |
20 May 2022 |
1 |
+$6,000 |
4 |
President and CEO, Director, 10%+ Owner |
23 May 2022, 16:57 |
| IKT |
Inhibikase Therapeutics, Inc. |
07 Mar 2022 |
1 |
$0 |
4 |
President and CEO, Director, 10%+ Owner |
21 Mar 2022, 16:05 |
| IKT |
Inhibikase Therapeutics, Inc. |
07 Mar 2022 |
1 |
$0 |
4 |
President and CEO, Director, 10%+ Owner |
09 Mar 2022, 19:21 |
| IKT |
Inhibikase Therapeutics, Inc. |
03 Jan 2022 |
2 |
+$44,143 |
4 |
President and CEO, Director, 10%+ Owner |
04 Jan 2022, 20:25 |
| IKT |
Inhibikase Therapeutics, Inc. |
17 Nov 2021 |
5 |
+$46,558 |
4 |
President and CEO, Director, 10%+ Owner |
19 Nov 2021, 07:13 |
| IKT |
Inhibikase Therapeutics, Inc. |
17 Aug 2021 |
2 |
+$44,143 |
4 |
President and CEO, Director, 10%+ Owner |
19 Aug 2021, 07:46 |
| IKT |
Inhibikase Therapeutics, Inc. |
14 May 2021 |
3 |
-$61,045 |
4 |
President and CEO, Director, 10%+ Owner |
18 May 2021, 17:46 |